Drug Profile
JTK 656
Alternative Names: JTK-656Latest Information Update: 08 Dec 2011
Price :
$50
*
At a glance
- Originator Japan Tobacco
- Class Antiretrovirals
- Mechanism of Action HIV integrase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 31 Oct 2011 Discontinued - Phase-I for HIV infections (PO)
- 30 Oct 2008 Phase-I clinical trials in HIV infections (PO)